Anne Finucane Net Worth

The estimated Net Worth of Anne A. Finucane is at least $744 Thousand dollars as of 30 May 2023. Ms. Finucane owns over 1,328 units of CVS Health Corp stock worth over $156,170 and over the last 13 years she sold CVS stock worth over $267,230. In addition, she makes $321,000 as Independent Director at CVS Health Corp.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Ms. Finucane CVS stock SEC Form 4 insiders trading

Anne has made over 5 trades of the CVS Health Corp stock since 2012, according to the Form 4 filled with the SEC. Most recently she exercised 1,328 units of CVS stock worth $105,921 on 30 May 2023.

The largest trade she's ever made was selling 2,000 units of CVS Health Corp stock on 4 January 2016 worth over $191,740. On average, Anne trades about 129 units every 95 days since 2011. As of 30 May 2023 she still owns at least 1,958 units of CVS Health Corp stock.

You can see the complete history of Ms. Finucane stock trades at the bottom of the page.

Anne Finucane biography

Anne M. Finucane is Independent Director of Cvs Caremark Corp. Ms. Finucane has been Vice Chairman of Bank of America Corporation, an international financial services company, since July 2015 and is a member of its executive management team. From 2006 through July 2015 Ms. Finucane served as Global Chief Strategy and Marketing Officer for Bank of America and served as Northeast Market President from 2004 through July 2015. During her twenty-plus years as a senior leader at Bank of America and its legacy firms, Ms. Finucane has served as senior advisor to four chief executive officers and the Board of Directors. Ms. Finucane is responsible for the strategic positioning of Bank of America and oversees the public policy, customer research and analytics, global marketing, communications and corporate social responsibility efforts for the company. She is chair of Bank of America’s Environmental, Social and Governance Committee, and is also chair of the Bank of America Charitable Foundation. B.A., University of New Hampshire.

What is the salary of Anne Finucane?

As the Independent Director of CVS Health Corp, the total compensation of Anne Finucane at CVS Health Corp is $321,000. There are 13 executives at CVS Health Corp getting paid more, with Larry Merlo having the highest compensation of $36,451,700.

How old is Anne Finucane?

Anne Finucane is 66, she's been the Independent Director of CVS Health Corp since 2011. There are 6 older and 21 younger executives at CVS Health Corp. The oldest executive at CVS Health Corp is Tony White, 73, who is the Independent Director.

What's Anne Finucane's mailing address?

Anne's mailing address filed with the SEC is 3250, Van Ness Avenue, San Francisco, California, 94109, United States.

Insiders trading at CVS Health Corp

Over the last 21 years, insiders at CVS Health Corp have traded over $183,836,314 worth of CVS Health Corp stock and bought 414,134 units worth $17,067,837 . The most active insiders traders include Michael F Mahoney, Thomas M Ryan, and Larry J Merlo. On average, CVS Health Corp executives and independent directors trade stock every 25 days with the average trade being worth of $7,006,358. The most recent stock trade was executed by Prem S Shah on 16 February 2024, trading 29,473 units of CVS stock currently worth $2,267,947.

What does CVS Health Corp do?

CVS Health Corporation is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands.

Complete history of Ms. Finucane stock trades at CVS Health Corp and Williams-Sonoma

CVS Health Corp executives and stock owners

CVS Health Corp executives and other stock owners filed with the SEC include:

• Larry Merlo,
  President, Chief Executive Officer, Director
• Thomas Moriarty,
  Executive Vice President, General Counsel, Chief Policy and External Affairs Officer
• Jonathan Roberts,
  Chief Operating Officer, Executive Vice President
• Eva Boratto,
  Chief Financial Officer, Executive Vice President
• Troyen Brennan,
  Executive Vice President, Chief Medical Officer
• Eva C. Boratto,
  Exec. VP & CFO
• Jonathan C. Roberts,
  Exec. VP & COO
• Karen Sue Lynch,
  Pres, CEO & Director
• Dr. Alan M. Lotvin,
  Exec. VP & Pres of CVS Caremark
• David Dorman,
  Independent Chairman of the Board
• Edward Ludwig,
  Independent Director
• C. David Brown,
  Independent Director
• Nancy-Ann DeParle,
  Independent Director
• Anne Finucane,
  Independent Director
• Tony White,
  Independent Director
• Jean-Pierre Millon,
  Independent Director
• Alecia DeCoudreaux,
  Independent Director
• William Weldon,
  Independent Director
• Mary Schapiro,
  Independent Director
• Roger Farah,
  Independent Director
• Fernando Aguirre,
  Independent Director
• James Clark,
  Senior Vice President - Controller, Chief Accounting Officer
• Karen Lynch,
  Executive Vice President
• Alan Lotvin,
  Executive Vice President, President - CVS Caremark
• Joshua Flum,
  Executive Vice President - Enterprise Strategy and Digital
• Lisa Bisaccia,
  Chief Human Resource Officer, Executive Vice President
• Norman de Greve,
  Chief Marketing Officer & Director
• Thomas Michael Moriarty,
  Exec. VP, Chief Policy & External Affairs Officer and Gen. Counsel
• Susan V. Lisa,
  Sr. VP of Investor Relations
• James David Clark,
  Sr. VP, Controller & Chief Accounting Officer
• Shawn Michael Guertin,
  Exec. VP & CFO
• Katie Durant,
  Sr. Director of Investor Relations
• Eileen Howard Boone,
  Sr. VP & Chief Sustainability Officer
• Laurie P. Havanec,
  Exec. VP & Chief People Officer
• David A. Falkowski,
  Exec. VP & Chief Compliance Officer
• Valerie C. Haertel,
  Sr. VP of Investor Relations
• Neela Montgomery,
  EVP and Pres., Pharmacy/Retail
• J. David Joyner,
  EVP&President-PharmacyServices
• Andrew Sussman,
  SVP & President, MinuteClinic
• Richard M Bracken,
  Director
• Robert O. Kraft,
  EVP and President - Omnicare
• Richard J Swift,
  Director
• David M Denton,
  Controller
• Stephen J Gold,
  SVP & CIO
• Jonathan E. Mayhew,
  EVP - Transformation
• Kevin Hourican,
  EVP & President, CVS Pharmacy
• Mark T Bertolini,
  Director
• Derica W Rice,
  EVP & President, CVS Caremark
• Helena Foulkes,
  Senior Vice President
• Kristen Gibney Williams,
  Director
• C A Piccolo,
  Director
• Mark Cosby,
  EVP & President-CVS/pharmacy
• Laird Daniels,
  SVP, Cont & Chief Acct Officer
• Howard A Mclure,
  President, Caremark Pharm Serv
• Chris W Bodine,
  Executive Vice President
• Paula A Price,
  Controller
• Edwin M Banks,
  Director
• David B Rickard,
  Chief Financial Officer
• V Michael Ferdinandi,
  Senior Vice President
• Roger L Headrick,
  Director
• William R Spalding,
  EVP Caremark Pharmacy Services
• Edwin M Crawford,
  Chairman
• Stuart M Mcguigan,
  SVP and CIO
• Thomas M Ryan,
  Chairman & CEO
• Terrence Murray,
  Director
• Marian L Heard,
  Director
• Sara Finley,
  SVP, Gen Counsel
• Douglas A Sgarro,
  Vice President
• Sheli Z Rosenberg,
  Director
• William H Joyce,
  Director
• W Don Cornwell,
  Director
• Gregory S Weishar,
  Vice President
• Alfred J Verrecchia,
  Director
• Larry D Solberg,
  Senior Vice President
• Stanley P Goldstein,
  Director
• Thomas P Gerrity,
  Director
• Terry R Lautenbach,
  Director
• Per Gh Lofberg,
  President, Caremark Pharm Serv
• Thomas F. Cowhey,
  SVP, Interim CFO
• Brian A Kane,
  EVP/President, Aetna
• Laurie P. Havanec,
  EVP and Chief People Officer
• J Scott Kirby,
  Director
• Daniel P Finke,
  EVP/Pres, Health Care Benefits
• Prem S Shah,
  EVP and Pres-Pharm, Consumer W
• Shawn M Guertin,
  EVP & Chief Financial Officer
• Michelle A Peluso,
  EVP and Co-President of Retail
• Sreekanth K Chaguturu,
  EVP and Chief Medical Officer
• Jeffrey R. Balser,
  Director
• Tilak Mandadi,
  EVP, Chief Technology Officer
• Samrat S. Khichi,
  EVP, CPO and General Counsel
• Michael F Mahoney,
  Director